According to a new report released on 9 April 2013 by the US Centers for Disease Control and Prevention, adults in the US used several strategies to reduce the costs of their medications, including asking their doctor for a lower-cost (generic) medicine.
Patients in US turn to generics to save money
Home/Reports | Posted 19/04/2013 0 Post your comment
The results of the 2011 National Health Interview Survey (NHIS) showed that adults aged 18–64 (19.8%) and those aged 65 and over (20.3%) were equally likely to ask their doctor for a lower-cost medication to save money. On the other hand, 18–64 year-olds (12.6%) were more than twice as likely as adults ≥ 65 years (5.8%) to not have taken medication as prescribed to save money.
Adults aged 18–64 (6%) were also more likely to save money by using alternative therapies compared with adults ≥ 65 years (2.3%). About 2% of all adults bought prescription drugs from another country to save money.
Among adults aged 18–64, uninsured adults (23.1%) were more likely than those with Medicaid (13.6%) or those with private coverage (8.7%) to not have taken medication as prescribed to save money. Whereas in adults ≥ 65 years, those with only Medicare coverage were more likely to ask their doctor for a lower-cost medication to save money (24.9%) compared with those who had private coverage (20.1%) and those with Medicare and Medicaid (14.7%) coverage.
Adults who were poor (18–64 years, 19.7%; ≥ 65 years, 9.0%) or near poor (18–64 years, 18.1%; ≥ 65 years, 9.4%) were found to be twice as likely to not take medication as prescribed in order to save money compared to adults who were not poor (18–64 years, 9.6%; ≥ 65 years, 4.0%). Whereas patients who were near poor (18–64 years, 22.2%; ≥ 65 years, 24.0%) were more likely than those who were poor (18–64 years, 20.4%; ≥ 65 years, 15.1%) and those who were not poor (18–64 years, 19.0%; ≥ 65 years, 19.8%) to ask their doctor for a lower-cost medication to save money.
The report noted that it focused only on cost-related strategies used by adults to reduce their prescription medication costs, and that there are also other barriers to medication adherence including those not related to cost that are not measured in NHIS years.
Permission granted to reproduce for personal and educational use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.
Source: CDC
Guidelines
Regulatory update for post-registration of biological products in Brazil
New regulations in Brazil for the registration of biosimilars
Policies & Legislation
NPRA Malaysia trials new timelines for variation applications
Regulatory evolution and impact of simplified requirements for interchangeable biosimilars in the US
Comments (0)
Post your comment